Aptevo Therapeutics's total assets for Q1 2026 were $19.90M, a decrease of -26.81% from the previous quarter. APVO total liabilities were $8.29M for the fiscal quarter, a -15.52% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.